Skip to main content
Top
Published in: International Urology and Nephrology 5/2023

12-01-2023 | Overactive Bladder | Urology - Letter to the Editor

Letter to the editor re: Surgical outcome of male patients with chronic central nervous system disorders and voiding dysfunction due to bladder outlet obstruction. Chang TL, Chen SF, Kuo HC. Int Urol Nephrol. 2022 Oct;54(10):2511–2519. doi: 10.1007/s11255-022-03285-3. Epub 2022 Jul 11

Authors: I. M. Pina, R. N. Khadr, M. S. Floyd Jr

Published in: International Urology and Nephrology | Issue 5/2023

Login to get access

Excerpt

We read with interest the recent publication by Chang et al. detailing the effects of bladder outlet surgery in male patients with voiding dysfunction due to chronic central nervous system disorders [1]. …
Literature
7.
go back to reference Kapoor S, Bourdoumis A, Mambu L et al (2013) Effective management of lower urinary tract dysfunction in idiopathic Parkinson’s disease. Int J Urol 20:79–84CrossRefPubMed Kapoor S, Bourdoumis A, Mambu L et al (2013) Effective management of lower urinary tract dysfunction in idiopathic Parkinson’s disease. Int J Urol 20:79–84CrossRefPubMed
Metadata
Title
Letter to the editor re: Surgical outcome of male patients with chronic central nervous system disorders and voiding dysfunction due to bladder outlet obstruction. Chang TL, Chen SF, Kuo HC. Int Urol Nephrol. 2022 Oct;54(10):2511–2519. doi: 10.1007/s11255-022-03285-3. Epub 2022 Jul 11
Authors
I. M. Pina
R. N. Khadr
M. S. Floyd Jr
Publication date
12-01-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 5/2023
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-022-03453-5

Other articles of this Issue 5/2023

International Urology and Nephrology 5/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine